Riskpilot← Back to searchSign inGet full accessBlacon AB
ABActiveOrg 5569641441Falkvägen 17Research and experimental development on natural sciences and engineering · NACE 7210Est. 20141 employees
Revenue 2025
SEK 0
EBITDA margin
—
-292% vs 2024
Equity ratio
77.2%
Financial strength
Net profit 2025
SEK 451K
+22% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -225K | -292% |
| Net profit | SEK 451K | +22% |
| Total assets | SEK 6,6M | +2% |
| Equity | SEK 5,1M | +5% |
| Employees | 1 | — |
Legal name
Blacon AB
Org number
5569641441
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
5 mars 2014
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska verka som ett konsultbolag för utveckling av ny metodik och teknologi inom området som sysslar med att utnyttja spårmolekyler inom den biologiska sektorn alltifrån diagnostik, terapi i det medicinska fältet och som forskningsverktyg inom bioenergiforskning samt därmed förenlig verksamhet.
Address
Falkvägen 17
Email
bengt.langstrom@kemi.uu.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 223 | 1 251 | 1 348 | 462 | 0 |
| Staff expenses | — | — | — | −219 | — |
| EBITDA | 758 | 913 | 880 | 117 | −225 |
| Depreciation & amort. | −0 | −0 | −0 | −18 | −109 |
| EBIT | 758 | 913 | 880 | 99 | −334 |
| Net financials | 26 | −5 | — | 15 | 855 |
| Profit before tax | 740 | 928 | 856 | 493 | 581 |
| Tax | −166 | −203 | −192 | −123 | −130 |
| Net profit | 574 | 725 | 664 | 370 | 451 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 5 648 | 6 159 | 6 676 | 6 454 | 6 574 |
| Equity | 3 661 | 4 199 | 4 669 | 4 835 | 5 077 |
| Long-term debt | 0 | 0 | 0 | — | 0 |
| Short-term debt | 97 | 90 | 113 | 105 | 43 |
| Total debt | 97 | 90 | 113 | 105 | 43 |
EBITDA margin
-22500000.0%
This company
15.8%
Market median
-142405163% vs market
20212025
Equity ratio
77.2%
This company
38.2%
Market median
+102% vs market
20212025
Return on equity
8.9%
This company
18.4%
Market median
-52% vs market
20212025
Net profit margin
45100000.0%
This company
8.1%
Market median
+556790023% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.29×
This company
0.62×
Market median
+53% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
SH | Audit | 2022 |
BR Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Blacon AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sven Håkan Daniel Fjelner | Audit | 0 companies |
| Bengt Roland Långström | Chief Executive Officer | 0 companies |
| Jonas Olof Jansén | Deputy Board Member | 0 companies |